These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17909076)

  • 61. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Autopsy findings and pattern of mortality in Nigerian sickle cell disease patients.
    Ogun GO; Ebili H; Kotila TR
    Pan Afr Med J; 2014; 18():30. PubMed ID: 25368719
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort.
    Tartaglione I; Strunk C; Antwi-Boasiako C; Andemariam B; Colombatti R; Asare EV; Piccone CM; Manwani D; Boruchov D; Tavernier F; Farooq F; Akatue S; Oteng B; Urbonya R; Wilson S; Owda A; Bamfo R; Boatemaa GD; Rao S; Zempsky W; Sey F; Inusa BP; Perrotta S; Segbefia C; Campbell AD
    Blood Cells Mol Dis; 2021 May; 88():102531. PubMed ID: 33401140
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Which Febrile Children With Sickle Cell Disease Need a Chest X-Ray?
    Eisenbrown K; Nimmer M; Ellison AM; Simpson P; Brousseau DC
    Acad Emerg Med; 2016 Nov; 23(11):1248-1256. PubMed ID: 27404765
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Polymorphisms in Inflammatory Genes Modulate Clinical Complications in Patients With Sickle Cell Disease.
    Tozatto-Maio K; Girot R; Ly ID; Silva Pinto AC; Rocha V; Fernandes F; Diagne I; Benzerara Y; Dinardo CL; Soler JP; Kashima S; Araujo IL; Kenzey C; Fonseca GHH; Rodrigues ES; Volt F; Jarduli L; Ruggeri A; Mariaselvam C; Gualandro SFM; Rafii H; Cappelli B; Nogueira FM; Scigliuolo GM; Guerino-Cunha RL; Malmegrim KCR; Simões BP; Gluckman E; Tamouza R
    Front Immunol; 2020; 11():2041. PubMed ID: 33013863
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Acute encephalic manifestations in Senegalese children with sickle cell disease].
    Diagne I; Diagne-Guèye NR; Fall L; Ndiaye O; Camara B; Diouf S; Signate-Sy H; Kuakuvi N
    Dakar Med; 2001; 46(2):116-20. PubMed ID: 15773177
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Declining stroke rates in Californian children with sickle cell disease.
    Fullerton HJ; Adams RJ; Zhao S; Johnston SC
    Blood; 2004 Jul; 104(2):336-9. PubMed ID: 15054044
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The intersection between asthma and acute chest syndrome in children with sickle-cell anaemia.
    DeBaun MR; Strunk RC
    Lancet; 2016 Jun; 387(10037):2545-53. PubMed ID: 27353685
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Association of Guideline-Adherent Antibiotic Treatment With Readmission of Children With Sickle Cell Disease Hospitalized With Acute Chest Syndrome.
    Bundy DG; Richardson TE; Hall M; Raphael JL; Brousseau DC; Arnold SD; Kalpatthi RV; Ellison AM; Oyeku SO; Shah SS
    JAMA Pediatr; 2017 Nov; 171(11):1090-1099. PubMed ID: 28892533
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Opioids are not a major cause of death of patients with sickle cell disease.
    Ballas SK
    Ann Hematol; 2021 May; 100(5):1133-1138. PubMed ID: 33758998
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs.
    Blinder MA; Vekeman F; Sasane M; Trahey A; Paley C; Duh MS
    Pediatr Blood Cancer; 2013 May; 60(5):828-35. PubMed ID: 23335275
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
    Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM
    Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neonatal Screening and the Clinical Outcome in Children with Sickle Cell Disease in Central India.
    Upadhye DS; Jain DL; Trivedi YL; Nadkarni AH; Ghosh K; Colah RB
    PLoS One; 2016; 11(1):e0147081. PubMed ID: 26785407
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prognostic value of left ventricular longitudinal strain by speckle-tracking echocardiography in patients with sickle cell disease.
    Resende MBS; Ferrari TCA; Araujo CG; Vasconcelos MCM; Tupinambás JT; Dias RCTM; Barros FC; Januário JN; Barbosa MM; Nunes MCP
    Int J Cardiovasc Imaging; 2020 Nov; 36(11):2145-2153. PubMed ID: 32621039
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Acute Chest Syndrome After Splenectomy in Children With Sickle Cell Disease.
    El-Gohary Y; Fleming A; Zhang H; Estepp JH; Hankins JS; Wang W; Davidoff AM; Murphy AJ
    J Surg Res; 2019 Oct; 242():336-341. PubMed ID: 31129243
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prevalence and risk factors for venous thromboembolism in children with sickle cell disease: an administrative database study.
    Kumar R; Stanek J; Creary S; Dunn A; O'Brien SH
    Blood Adv; 2018 Feb; 2(3):285-291. PubMed ID: 29431623
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia.
    Boyd JH; Macklin EA; Strunk RC; DeBaun MR
    Blood; 2006 Nov; 108(9):2923-7. PubMed ID: 16690969
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Acute clinical events in 299 homozygous sickle cell patients living in France. French Study Group on Sickle Cell Disease.
    Neonato MG; Guilloud-Bataille M; Beauvais P; Bégué P; Belloy M; Benkerrou M; Ducrocq R; Maier-Redelsperger M; de Montalembert M; Quinet B; Elion J; Feingold J; Girot R
    Eur J Haematol; 2000 Sep; 65(3):155-64. PubMed ID: 11007050
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.
    Mirre E; Brousse V; Berteloot L; Lambot-Juhan K; Verlhac S; Boulat C; Dumont MD; Lenoir G; de Montalembert M
    Eur J Haematol; 2010 Mar; 84(3):259-65. PubMed ID: 19912310
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Acute kidney injury in paediatric patients with sickle cell disease is associated with increased morbidity and resource utilization.
    McCormick M; Richardson T; Warady BA; Novelli EM; Kalpatthi R
    Br J Haematol; 2020 May; 189(3):559-565. PubMed ID: 32030722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.